NCT02381561 2026-03-18
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
RenJi Hospital
Swiss Cancer Institute
Masonic Cancer Center, University of Minnesota